These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 224851)

  • 41. [Nasopharyngeal carcinoma and the Epstein-Barr virus].
    Boger-Goren S; Gotlieb-Stematsky T
    Harefuah; 1985 May; 108(10):514-6. PubMed ID: 2995214
    [No Abstract]   [Full Text] [Related]  

  • 42. Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma.
    Zhang JX; Chen HL; Zong YS; Chan KH; Nicholls J; Middeldorp JM; Sham JS; Griffin BE; Ng MH
    J Med Virol; 1998 Jul; 55(3):227-33. PubMed ID: 9624611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In situ detection of Epstein-Barr virus markers in nasopharyngeal carcinoma patients.
    Lung ML; Chan KH; Lam WP; Kou SK; Choy D; Chan CW; Ng MH
    Oncology; 1989; 46(5):310-7. PubMed ID: 2550863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The nasopharyngeal carcinoma and Epstein-Barr virus (EBV) specific IgA (author's transl)].
    Desgranges C
    Pathol Biol (Paris); 1981 Dec; 29(10):587-9. PubMed ID: 6280123
    [No Abstract]   [Full Text] [Related]  

  • 45. Epstein-Barr virus-determined nuclear antigen in malignant epithelial cells of nasopharyngeal carcinoma.
    Suzuki T; Katano A; Oboshi S; Sairenji T; Hinuma Y
    Gan; 1978 Feb; 69(1):133-8. PubMed ID: 205477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma.
    Akao I; Sato Y; Mukai K; Sugano S; Hoshikawa T; Suzuki T; Tsutsumi K
    Acta Otolaryngol Suppl; 1996; 522():86-8. PubMed ID: 8740817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological characterization of an Epstein-Barr nuclear antigen-positive American Burkitt's tumor-derived cell line.
    Hillman EA; Charamella LJ; Temple MJ; Elser JE
    Cancer Res; 1977 Dec; 37(12):4546-58. PubMed ID: 200355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Superinfection of human lymphoblastoid cells with EB virus (author's transl)].
    Vlcková I; Vonka V
    Cesk Epidemiol Mikrobiol Imunol; 1975 Jan; 24(1):3-8. PubMed ID: 165904
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
    Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
    Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nasopharyngeal carcinoma (NPC) mortality rate in two districts of Guangdong Province and their relation to IgA antibody level against EB virus capsid antigen].
    Zong YS
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):103-5. PubMed ID: 1319889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus and nasopharyngeal carcinoma: is there an etiologic relationship?
    Henderson BE; Louie EW; Jing JS; Alena B
    J Natl Cancer Inst; 1977 Nov; 59(5):1393-5. PubMed ID: 198562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Epstein-Barr virus nuclear antigen (EBNA) assay of the puncture smears from neck masses for the differential diagnosis of nasopharyngeal carcinoma].
    Chen QB
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):29-30. PubMed ID: 2983959
    [No Abstract]   [Full Text] [Related]  

  • 53. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1979 Dec; 58(12):911-5. PubMed ID: 231716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].
    Chen XY; Ning S; Arrand JR
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug; 23(4):200-3. PubMed ID: 7805145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
    Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
    Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on Epstein-Barr virus-associated antigens.
    Ernberg I
    Ann N Y Acad Sci; 1975 Jun; 254():516-22. PubMed ID: 170849
    [No Abstract]   [Full Text] [Related]  

  • 57. Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -D.
    Sun R; Wang X; Li X
    Med Sci Monit; 2015 Jul; 21():2105-9. PubMed ID: 26191775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Lymphoepithelioma-like" thymic carcinoma: another tumor related to Epstein-Barr virus?
    Rosai J
    N Engl J Med; 1985 May; 312(20):1320-2. PubMed ID: 2985994
    [No Abstract]   [Full Text] [Related]  

  • 59. Anticomplement immunoenzymatic method of detecting Epstein-Barr nuclear antigen in nasopharyngeal carcinoma cells and normal epithelial cells.
    Zeng Y; Shen SJ; Pi GH; Ma JL; Zhang Q; Zhao ML; Dong HJ
    Chin Med J (Engl); 1981 Oct; 94(10):663-8. PubMed ID: 6274591
    [No Abstract]   [Full Text] [Related]  

  • 60. [Carcinoma of the rhinopharynx in France, and the Epstein-Barr virus. Presence of Epstein-Barr nuclear antigen in tumor tissue].
    Seigneurin JM; Junien-Lavillauroy C; Roux O; Bolla M; Kressmann MC; Couderc P
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1980 Oct; 29(8):535-8, 541-4. PubMed ID: 6255060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.